Table 4.
Identification of MTB clinical isolates by DST, RDB and DNA sequencing
| Strain no. | DST | RDB | DNA sequencing |
| 1 | None | N1 missing | WT |
| 1 | None | 306N, 306M missing | WT |
| 1 | R, I, S, E | S531L, 43M, M306L | S531L(TCG/TTG) K43R(AAG/AGG) M306L(ATG/GTG) |
| 1 | I | WT | P388P(CCG/CCA) |
| 1 | R | D516V, 15N, 15M missing | D516V(GAC/CCA) |
| 1 | R, I, S | H526D, 315M, 88M | H526D(CAC/GAC) S315T(AGC/ACC) K88R(AAG/AGG) |
| 1 | R | H526D | H526D(CAC/AAC) |
| 2 | I | 315M | S315T(AGC/ACC) |
| 1 | R, I, S | S531L, 315M, 43M | S531L(TCG/TTG) S315T(AGC/ACC) K43R(AAG/AGG) |
| 1 | E | WT | WT |
| 42 | None | WT | WT |
DST, drug susceptibility testing; E, EMB-resistant; I, INH-resistant; MTB, Mycobacterium tuberculosis; R, RFP-resistant; RDB, reverse dot blot; S, SM-resistant; WT, wild-type sequencing.